Research Article

Cost-Effectiveness and Budget Impact Analyses of Pneumococcal Vaccination in Indonesia

Table 2

Budget impact analysis of PCV13 vaccination in Indonesia.

Year201920202021202220232024

Province/district
NTBNTBIndonesiaIndonesiaIndonesiaIndonesia
Bangka BelitungBangka Belitung
Kota BogorDKI Jakarta
Kota BekasiJawa Barat
Kota SurabayaJawa Timur
Gresik
Sidoarjo
Total provinces4534343434
Total districts2288514514514514
Total birth cohort399,1461,723,6004,712,5004,678,3004,638,2004,600,600
Total targeted population374,8661,618,7534,425,8374,393,7184,356,0574,323,518
Total number of vaccine required1,180,8285,099,07213,941,38713,840,21213,721,58013,619,082
Total introduction cost of PCV13$198,211$733,378$4,187,641$4,187,641$4,196,448$4,195,405
Introduction cost of PCV13 per child$0.91
Total national healthcare budget$4,439,025,459$4,502,303,273$4,566,483,106$4,631,577,814$4,697,600,441$4,764,564,213
Total routine immunization budget$377,811,070$374,478,982$539,164,943$523,553,250$574,860,622$574,349,928

UNICEF price
Total vaccination cost of PCV13$5,378,643$21,880,629$75,006,787$74,462,451$73,824,193$73,272,738
Vaccination cost per child (3 doses)$16.61
Total vaccination cost of PCV13, compared with healthcare budget (%)0.12%0.49%1.64%1.61%1.57%1.54%
Total vaccination cost of PCV13, compared with routine immunization budget (%)1.42%5.84%13.91%14.22%12.84%12.76%

Government contract price
Total vaccination cost of PCV13$22,317,647$96,372,460$263,492,206$261,580,001$259,337,855$257,400,644
Vaccination cost per child (3 doses)$59.54
Total vaccination cost of PCV13, compared with healthcare budget (%)0.50%2.14%5.77%5.65%5.52%5.40%
Total vaccination cost of PCV13, compared with routine immunization budget (%)5.91%25.74%48.87%49.96%45.11%44.82%

Surviving infant x vaccination coverage, 3 doses of vaccine required + buffer stock (5%), including social mobilization/IEC, microplanning, training, supervision, and monitoring, vaccine price ($3,3 1-dose; $2,95 4-dose nationwide) + tax (10%) + import duty (5%) + forwarder (2,5%) + distribution (12%) + wastage cost (25% for 4-dose presentation), according to government contract in 2017, district, province, and national.